Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 13, 2021

SELL
$8.11 - $11.11 $1.22 Million - $1.67 Million
-150,000 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$9.85 - $17.69 $870,789 - $1.56 Million
88,405 Added 143.53%
150,000 $1.57 Million
Q4 2020

Feb 10, 2021

BUY
$14.15 - $17.19 $871,569 - $1.06 Million
61,595 New
61,595 $953,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Junson Asset Management (Hong Kong) LTD Portfolio

Follow Junson Asset Management (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Junson Asset Management (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Junson Asset Management (Hong Kong) LTD with notifications on news.